Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances and Progress on Melanin: From Source to Application. | Int J Mol Sci | 2023 | 36901791 | PubTator, text mining | PubMed |
| Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular Degeneration. | Cells | 2023 | 36899910 | PubTator, text mining | PubMed |
| Mortality of Malignant Melanoma in Central Serbia, in the Period 1999-2015. | Dermatol Pract Concept | 2023 | 36892369 | PubTator, text mining | PubMed |
| Whole-genome sequencing reveals a complex African population demographic history and signatures of local adaptation. | Cell | 2023 | 36868214 | PubTator, text mining | PubMed |
| Single-Cell Characterization of the Frizzled 5 (Fz5) Mutant Mouse and Human Persistent Fetal Vasculature (PFV). | Invest Ophthalmol Vis Sci | 2023 | 36867129 | PubTator, text mining | PubMed |
| Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy. | Cancer Res Commun | 2023 | 36860656 | PubTator, text mining | PubMed |
Emergence of colistin resistance and characterization of antimicrobial resistance and virulence factors of Aeromonas hydrophila, Salmonella spp., and Vibrio cholerae isolated from hybrid red tilapia cage culture. | PeerJ | 2023 | 36855429 | PubTator, text mining | PubMed |
| The mechanism of Croci stigma in the treatment of melasma based on network pharmacology and molecular docking. | J Cosmet Dermatol | 2023 | 36852722 | PubTator, text mining | PubMed |
| Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model. | Mol Ther Methods Clin Dev | 2023 | 36851984 | PubTator, text mining | PubMed |
Comparison of Proanthocyanidin Content in Rabbiteye Blueberry (Vaccinium virgatum Aiton) Leaves and the Promotion of Apoptosis against HL-60 Promyelocytic Leukemia Cells Using 'Kunisato 35 Gou' Leaf Extract. | Plants (Basel) | 2023 | 36840296 | PubTator, text mining | PubMed |
| Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia. | Pharmaceutics | 2023 | 36839793 | PubTator, text mining | PubMed |
| Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy. | Pharmaceutics | 2023 | 36839774 | PubTator, text mining | PubMed |
| Tyrosinase Immobilization Strategies for the Development of Electrochemical Biosensors-A Review. | Nanomaterials (Basel) | 2023 | 36839128 | PubTator, text mining | PubMed |
| High-Molecular-Weight Plasmids Carrying Carbapenemase Genes blaNDM-1, blaKPC-2, and blaOXA-48 Coexisting in Clinical Klebsiella pneumoniae Strains of ST39. | Microorganisms | 2023 | 36838424 | PubTator, text mining | PubMed |
| Inhibition of Melanogenesis by Essential Oils from the Citrus Cultivars Peels. | Int J Mol Sci | 2023 | 36835634 | PubTator, text mining | PubMed |
| Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas. | Genes (Basel) | 2023 | 36833366 | PubTator, text mining | PubMed |
| Chemical Constituents from Streblus taxoides Wood with Their Antibacterial and Antityrosinase Activities Plus in Silico Study. | Antibiotics (Basel) | 2023 | 36830230 | PubTator, text mining | PubMed |
| Antioxidant Potential-Rich Betel Leaves (Piper betle L.) Exert Depigmenting Action by Triggering Autophagy and Downregulating MITF/Tyrosinase In Vitro and In Vivo. | Antioxidants (Basel) | 2023 | 36829933 | PubTator, text mining | PubMed |
| The Role of Acetyl Zingerone and Its Derivatives in Inhibiting UV-Induced, Incident, and Delayed Cyclobutane Pyrimidine Dimers. | Antioxidants (Basel) | 2023 | 36829837 | PubTator, text mining | PubMed |
| Ethyl Gallate Isolated from Castanopsis cuspidata var. sieboldii Branches Inhibits Melanogenesis and Promotes Autophagy in B16F10 Cells. | Antioxidants (Basel) | 2023 | 36829827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=19